52 Grants (Page 2 of 3)
2009
The Role of Ape1 in Neurotoxicity of Cancer Treatments
Kelley, Mark R
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA121168-02), $404,126USD, 04/01/2008 -- 01/31/2013
 
The Role of Ape1 in Neurotoxicity of Cancer Treatments
Kelley, Mark R
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 3R01CA121168-02S1), $358,757USD, 08/01/2009 -- 07/31/2011
2008
Imbalancing DNA BER to enhance Ovarian Tumor Sensitivity
Kelley, Mark R
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA106298-05), $285,864USD, 05/01/2004 -- 04/30/2010
 
The Role of Ape1 in Neurotoxicity of Cancer Treatments
Kelley, Mark R
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 1R01CA121168-01A2), $434,754USD, 04/01/2008 -- 01/31/2013
2007
Imbalancing DNA BER to enhance Ovarian Tumor Sensitivity
Kelley, Mark R
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA106298-04), $286,256USD, 05/01/2004 -- 04/30/2009
 
Therapeutic/Mechanistic Role of Ape1 in Germ Cell Tumors
Kelley, Mark R
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA094025-05), $208,737USD, 08/05/2003 -- 07/31/2009
2006
Imbalancing DNA BER to enhance Ovarian Tumor Sensitivity
Kelley, Mark R
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA106298-03), $295,002USD, 05/01/2004 -- 04/30/2009
 
Therapeutic/Mechanistic Role of Ape1 in Germ Cell Tumors
Kelley, Mark R
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA094025-04), $214,971USD, 08/05/2003 -- 07/31/2008
2005
Imbalancing DNA BER to enhance Ovarian Tumor Sensitivity
Kelley, Mark R
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA106298-02), $308,525USD, 05/01/2004 -- 04/30/2009
 
Therapeutic/Mechanistic Role of Ape1 in Germ Cell Tumors
Kelley, Mark R
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA094025-03), $223,388USD, 08/05/2003 -- 07/31/2008
2004
Imbalancing DNA BER to enhance Ovarian Tumor Sensitivity
Kelley, Mark R
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 1R01CA106298-01), $308,525USD, 05/01/2004 -- 04/30/2009
 
Therapeutic/Mechanistic Role of Ape1 in Germ Cell Tumors
Kelley, Mark R
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA094025-02), $224,140USD, 08/05/2003 -- 07/31/2008
2003
OXIDATIVE DNA DAMAGE AND REPAIR IN CNS CELLS
Kelley, Mark R
National Institutes of Health (NIH), National Institute of Neurological Disorders and Stroke (NINDS) (ID: 5R01NS038506-04), $324,200USD, 02/14/2000 -- 01/31/2005
 
Therapeutic/Mechanistic Role of Ape1 in Germ Cell Tumors
Kelley, Mark R
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 1R01CA094025-01A2), $235,376USD, 08/05/2003 -- 07/31/2008
2002
CORE--CELL AND MOLECULAR BIOLOGY
Kelley, Mark R
National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (ID: 5P30DK049218-09), $228,564USD, 09/01/2002 -- 08/31/2003
 
OXIDATIVE DNA DAMAGE AND REPAIR IN CNS CELLS
Kelley, Mark R
National Institutes of Health (NIH), National Institute of Neurological Disorders and Stroke (NINDS) (ID: 5R01NS038506-03), $312,350USD, 02/14/2000 -- 01/31/2004
2001
CORE--CELL AND MOLECULAR BIOLOGY
Kelley, Mark R
National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (ID: 3P30DK049218-07S1), $228,564USD, 06/01/2001 -- 08/31/2001
 
CORE--CELL AND MOLECULAR BIOLOGY
Kelley, Mark R
National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (ID: 5P30DK049218-08), $228,564USD, 09/01/2001 -- 08/31/2002
 
OXIDATIVE DNA DAMAGE AND REPAIR IN CNS CELLS
Kelley, Mark R
National Institutes of Health (NIH), National Institute of Neurological Disorders and Stroke (NINDS) (ID: 5R01NS038506-02), $300,938USD, 02/14/2000 -- 01/31/2004
2000
CORE--CELL AND MOLECULAR BIOLOGY
Kelley, Mark R
National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (ID: 5P30DK049218-07), $120,834USD, 09/01/2000 -- 08/31/2001
 
OXIDATIVE DNA DAMAGE AND REPAIR IN CNS CELLS
Kelley, Mark R
National Institutes of Health (NIH), National Institute of Neurological Disorders and Stroke (NINDS) (ID: 1R01NS038506-01A1), $227,524USD, 02/14/2000 -- 01/31/2004
1999
CORE--CELL AND MOLECULAR BIOLOGY
Kelley, Mark R
National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (ID: 2P30DK049218-06), 09/15/1999 -- 08/31/2000
1996
MOLECULAR ANALYSIS OF DROSOPHILA AP ENDONUCLEASES
Kelley, Mark R
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 5R01RR009884-04), 09/30/1993 -- 09/29/1998
1995
MOLECULAR ANALYSIS OF DROSOPHILA AP ENDONUCLEASES
Kelley, Mark R
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 5R01RR009884-03), 09/30/1993 -- 09/29/1997
1994
MOLECULAR ANALYSIS OF DROSOPHILA AP ENDONUCLEASES
Kelley, Mark R
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 5R01RR009884-02), 09/30/1993 -- 09/29/1997